Rios v. Nevada CVS Pharmacy, LLC ( 2024 )

(#8805) 2 Kaine Messer (#14240) 3 GABROY | MESSER 170 South Green Valley Parkway, Suite 280 4 Henderson, Nevada 89012 Tel (702) 259-7777 5 Fax (702) 259-7704 christian@gabroy.com 6 kmesser@gabroy.com Attorneys for Plaintiffs 7 UNITED STATES DISTRICT COURT DISTRICT OF NEVADA 8 ROSA RIOS, as Special Administrator of Case No. 2:23-cv-01108 RFB-NJK 9 the Estate of ALEJANDRO RIOS, deceased; ELI RIOS, individually and as 10 Heir of the ESTATE OF ALEJANDRO STIPULATION AND ORDER TO RIOS, Deceased; ROSA RIOS, EXTEND DISCOVERY DEADLINES 11 individually and as Heir of the ESTATE OF ALEJANDRO RIOS, Deceased; ALEX (First Request) 12 RIOS, individually and as Heir of the ESTATE OF ALEJANDRO RIOS, 13 Deceased; ROSA MANCINAS ALVAREZ, individually and as Heir of the ESTATE OF 14 ALEJANDRO RIOS, Deceased; JESSICA LOPEZ, individually and as Heir of the 15 ESTATE OF ALEJANDRO RIOS, Deceased; 16 Plaintiffs, 17 vs. 18 NEVADA CVS PHARMACY, LLC, a Domestic Limited-Liability Company; CVS 19 PHARMACY, INC, a Foreign Corporation; CVS NV HOLDING COMPANY, L.L.C., a 20 Foreign Limited-Liability Company; CVS 1507 NV, L.L.C., a Foreign Limited-Liability 21 Company; NS RETAIL HOLDINGS, LLC, a Foreign Limited-Liability Company; CVS 22 HEALTH CORP, a Foreign Corporation; CAREMARK PHC, LLC, a Foreign Limited- 23 Liability Corporation; LAS VEGAS PHARMACY DST, a Foreign Statutory 24 Trust; PHARMACY PORTFOLIO IV EXCHANGE, L.L.C., A Foreign Limited- 25 Liability Company; INLAND PRIVATE CAPITAL CORPORATION, a Foreign 26 Corporation; DOES 1-10; AND ROE CORPORATIONS 11-20, DOE 27 EMPLOYEES/AGENTS 21-30, inclusive; 28 Defendants. 2 Pursuant to LR IA 6-1, 6-2, and LR 26-1, Plaintiffs, by and through their counsel 3 of record, and Defendants, by and through their counsel of record, hereby stipulate to 4 amend the current scheduling order (ECF No. 22) by extending the outstanding 5 discovery deadlines for a period of one hundred twenty (120) days. This is the first 6 request for an extension to the scheduling order in this matter. 7 This is a complex wrongful death matter involving multiple Plaintiffs in multiple 8 states to which Rosa Rios was appointed as Special Administrator of the Estate of 9 Alejandro Rios, multiple defendants in multiple jurisdictions, and the parties have been 10 engaging in discovery diligently throughout this matter to pursue the mandates of FRCP 11 1. 12 DISCOVERY COMPLETED TO DATE AND GOOD CAUSE REASONS FOR EXTENSION TO COMPLETE DISCOVERY 13 Fed. R. Civ. P. Rule 16(b)’s good cause standard looks primarily to the diligence 14 of the party seeking amendment. CC.Mexicano.US, LLC v. Aero II Aviation, Inc., No. 15 2:14-CV-00108-JCM-NJK, 2015 WL 10059063, at *2 (D. Nev. Dec. 5, 2015), report and 16 recommendation adopted sub nom. CC. Mexicano US, LLC v. Aero II Aviation, Inc., 17 No. 2:14-CV-108-JCM-NJK, 2016 WL 589668 (D. Nev. Feb. 11, 2016). The parties 18 proffer and respectfully state to this Honorable Court that such standard is readily met 19 in this matter. 20 The parties have exchanged their initial disclosures required under Fed. R. Civ. 21 P. 26(a)(1)(A) and continue to supplement such disclosures. Defendants Las Vegas 22 Pharmacy DST, Pharmacy Portfolio IV Exchange, LLC and Inland Private Capital 23 Corporation’s (“LL Defendants”) Initial Disclosure were tendered on August 29, 2023 24 and have been supplemented throughout discovery. 25 After extensive written discovery, meet and confers involving written 26 correspondence and phone calls, LL Defendants have tendered supplemental 27 disclosures and produced hundreds of pages of documents. LL Defendants and 28 2 depositions, continued authorizations needed or necessary for the Plaintiffs, any 3 stipulated protective order necessary, and responses to any discovery tendered by 4 Plaintiffs. 5 LL Defendants and Plaintiffs are working on an appropriate SAO per FRCP to 6 dismiss without prejudice some Defendants with appropriate stipulation for the 7 streamlining of this matter. 8 Throughout this matter, Plaintiffs have served and tendered over Four Thousand 9 (4,000) pages of disclosures. Defendants served their initial disclosures on August 29, 10 2023. Defendants Las Vegas Pharmacy DST, Pharmacy Portfolio IV Exchange, LLC, 11 and inland Private Capital Corporation served their first supplemental disclosures on 12 September 8, 2023. 13 Defendants Nevada CVS Pharmacy, LLC, CVS Pharmacy, Inc., CVS NV Holding 14 Company, L.L.C., CVS Healthcare Corporation, and Caremark PHC, LLC (CVS 15 Defendants) have served and tendered over 600 pages of disclosures. 16 As CVS Defendants are currently finalizing more disclosures, any appropriate 17 protective Order, authorizations, etc., more disclosures are anticipated and the parties 18 have been working together on appropriate language in a SAO to dismiss without 19 prejudice certain CVS Defendants for the streamlining of this matter. 20 Plaintiffs served their first set of requests to produce to Defendants Nevada CVS 21 Pharmacy, LLC, CVS Pharmacy, Inc., CVS NV Holding Company, L.L.C., CVS 22 Healthcare Corporation, and Caremark PHC, LLC. Responses were served on 23 November 13, 2023 and continuing throughout as the parties are working toward 24 appropriate language in any authorization and/or releases needed. 25 Plaintiffs have served their first set of requests to produce to Defendants Las 26 Vegas Pharmacy DST, Pharmacy Portfolio IV Exchange, LLC, and Inland Private 27 Capital Corporation and responses continue throughout. 28 2 Company, L.L.C., CVS Healthcare Corporation, and Caremark PHC, LLC served their 3 first sets of interrogatories and requests to produce on October 16, 2023. Responses 4 were served on December 6, 2023. 5 On January 19, 2024, Defendants Nevada CVS Pharmacy, LLC, CVS Pharmacy, 6 Inc., CVS NV Holding Company, L.L.C., CVS Healthcare Corporation, and Caremark 7 PHC, LLC served notice of thirty-eight (38) subpoenas, served such subpoenas, and 8 Plaintiffs have provided all authorizations necessary through meet and confer process. 9 Last week, Plaintiffs timely responded to CVS second set of requests to 10 produce. 11 Plaintiffs have met and conferred on dates in March and April and otherwise 12 pending indulgence from this Honorable Court to schedule dispositions of all witnesses 13 pending completion of final responses as the 14 Unfortunately, Plaintiff’s lead counsel was in ICU in January of 2024 for a 15 serious medical condition to which he is still receiving treatment. Just last month, 16 Plaintiff’s lead trial counsel fell ill, received emergency transport, and was hospitalized 17 with congestive pneumonia and is still treating, recovering, and moving forward. 18 Additionally and prior to such circumstances, Plaintiff’s lead trial counsel had to travel 19 out of state to be with and assist an ailing family member. Moreover, Plaintiff’s counsel 20 had a 67-witness fair hearing for a local doctor that opposing party in that matter 21 refused to continue. In addition, the firm of Plaintiff’s counsel also experienced 22 significant personnel turnover of legal staff further necessitating this extension and has 23 actively sought employees and provided the appropriate training, hiring, and 24 supervision to diligently pursue these matters. Finally, counsel for Defendants Las 25 Vegas Pharmacy DST, Pharmacy Portfolio IV Exchange, LLC, and Inland Private 26 Capital Corporation (David Gould, Esq.) is currently out on leave. The parties herein 27 continue to work together to complete discovery. 28 Plaintiffs’ counsel takes this extension request seriously, has personally 2 with Defendants’ counsel, has engaged in motion practice in this case, and such 3 amount of time and corresponding extension of dates will ensure the effective 4 completion of discovery in this matter. Plaintiffs’ counsel understand the nature of this 5 serious request to this Honorable Court and has adjusted commitments, his medical 6 treatments, work and personal obligations, and other matters to effectively meet this 7 Honorable Court’s due diligence requirements. 8 DISCOVERY THAT REMAINS TO BE COMPLETED 9 Plaintiffs anticipate taking Defendants’ FRCP 30(b)(6) depositions, the 10 depositions of identified witnesses, and those in the document production tendered last 11 month. Defendants intend to take the depositions of the Plaintiffs; fact witnesses; and 12 experts. Appropriate experts will be disclosed as necessary. 13 Further, additional discovery will be exchanged and a proposed protective order, 14 according to this Honorable Court’s appropriate wording will be submitted. The parties 15 are currently working together to finalize a proposed protective order. 16 PROPOSED REVISED DISCOVERY PLAN 17 1. Discovery Cut-Off Deadline 18 The discovery cut-off deadline shall be extended for one hundred twenty (120) 19 days from May 3, 2024 to Tuesday, September 3, 2024 (August 31, 2024 falls on a 20 Saturday and September 2, 2024 is a federal holiday). 21 2. Amending the Pleadings and Adding Parties 22 The date for filing motions to amend the pleadings or to add parties was 23 February 2, 2024 and has passed. The parties do not seek an extension of this 24 deadline. 25 3. Initial and Rebuttal Expert Witness Disclosures 26 The disclosure of any expert witnesses shall be extended and made sixty (60) 27 days before the discovery cut-off date, which is Friday, July 5, 2024. The disclosures of 28 any rebuttal experts shall be due 30 days after the initial disclosures of experts, which is 2 4. Dispositive Motions Deadline 3 The parties shall file dispositive motions thirty (30) days after the extended 4 discovery cut-off date, and therefore, not later than Thursday, October 3, 2024. 5 5. Joint Pretrial Order Deadline 6 If no dispositive motions are filed and, unless otherwise ordered by this Court, 7 the Joint Pretrial Order shall be filed thirty (30) days after the date set for filing 8 dispositive motions, and therefore, not later than Monday, November 4, 2024 9 (November 2, 2024 falls on a Saturday). In the event dispositive motions are filed, the 10 date for filing the Joint Pretrial Order shall be suspended until thirty (30) days after the 11 Court enters a ruling on the dispositive motions or otherwise by further order of the 12 Court. 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 6. Trial and Calendar Call 2 No trial has been set in this matter. 3 || Dated this 12th day of February 2024 by: 4 || Gaproy | MESSER WEINBERG WHEELER HUDGINS GUNN & DIAL 5 || By: /s/Christian Gabroy By: _/s/ Stephanie J. Glantz Christian Gabroy Phillip N. Smith, Jr. 6 || (#8805) (#10233) Kaine Messer Stephanie J. Glantz 7 | (414240) (#14878) GABROY | MESSER 6835 South Rainbow Boulevard 8 || 170 South Green Valley Parkway Suite 400 Suite 280 Las Vegas, NV 89118 9 || Henderson, Nevada 89012 Attorneys for Defendants Nevada CVS Attorneys for Plaintiffs Pharmacy, LLC; CVS Pharmacy, Inc.; CVS 10 NV Holding Company, L.L.C.; and CVS Health Corp; and Caremark PHC, LLC 11 || LEwis BRISBOIS BISGAARD & SMITH, LLP 12 || By: _4s/Josh Cole Aicklen Josh Cole Aicklen, 8 = 13 | (#7254) David Gould ASS 14 || (#11143) Pee 6385 South Rainbow Boulevard ==. 15 | Suite 600 2 28 Las Vegas, NV 89118 16 || Attorneys for Defendants Las Vegas Pharmacy DST; Pharmacy Portfolio [V a 17 Exchange, LLC; and Inland Private 18 Capital Corporation The Court is not inclined to grant further extensions hereafter. See 19 also Docket No. 22 at 2. 20 IT IS SO ORDERED. 21 . 53 UNITED STATES MAGISTRATE JUDGE 24 Dated: February 13, 2024 25 26 27 28 Page 7 of 7